Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email in the first instance.

 Information  X 
Enter a valid email address

Loudwater Trust Ltd (LWT)

  Print      Mail a friend

Wednesday 04 July, 2012

Loudwater Trust Ltd


RNS Number : 8739G
Loudwater Trust Limited
04 July 2012

Loudwater Trust Limited

Disposal of investment

4th July 2012


Loudwater Trust Limited ("Loudwater" or the "Company") (AIM: LWT) is pleased to announce the conditional disposal of its shareholding in AgraQuest, Inc. to Bayer Cropscience LLC, a subsidiary of Bayer AG, for an initial cash consideration of approximately £27.3 million or 45.4 pence per share, which compares to the carrying value of the investment as at 31 March 2012 of £6.8 million or 11.3 pence per share and an investment cost of £4.8 million, and the Company's current market capitalisation of £16.0 million or 26.5 pence per share.  Of this amount approximately £3.3 million will be initially held in escrow against potential indemnification claims.  In addition there is contingent consideration payable should AgraQuest achieve certain performance milestones in future years. The maximum contingent consideration that could be due to Loudwater is £3.5 million.   The initial proceeds from the disposal will be used to make a further cash return to shareholders.


Completion of the disposal is subject to satisfaction of a number of customary conditions including, regulatory clearances.


A further announcement will be made in due course on completion, together with an update on the return of cash to shareholders.


The full text of an announcement by Bayer Cropscience is set out below.


"Bayer CropScience acquires US-based biological company AgraQuest for close to US$ 500 million

Monheim, July 3, 2012 - Bayer CropScience announced today that it has signed an agreement to purchase AgraQuest Inc. for a purchase price of US$ 425 million (approximately EUR 340 million) plus milestone payments. AgraQuest, headquartered in Davis, California, USA, is a global supplier of innovative biological pest management solutions based on natural microorganisms. This acquisition will enable Bayer CropScience to build a leading technology platform for green products and to strengthen its strategically important fruits and vegetables business, while also opening new opportunities in other crops and markets. Green products control a broad spectrum of pests and diseases and offer farmers integrated pest management programs to minimize development of resistance and maximize crop yields. The acquisition is subject to approval by the relevant authorities.


"The growing fruits and vegetables market, which today accounts for more than 25 percent of our sales, is of strategic importance for us. We plan to achieve EUR 3 billion sales in this segment by 2020 and with the acquisition of AgraQuest we are underlining our growth ambitions," said Sandra Peterson, CEO of Bayer CropScience, sending a strong signal to the market. "We are the first in our industry to offer farmers a truly comprehensive range of integrated crop solutions based on seeds, traits and combined chemical crop protection and biological control," she added.


The tailor-made portfolio and promising R&D pipeline of AgraQuest will help Bayer CropScience to build a broad-based technology platform to bring a new generation of innovative products to the market. Furthermore, this acquisition will help to optimally use R&D, manufacturing and market synergies creating value for both Bayer CropScience and its customers. "AgraQuest expands our existing biological pest control portfolio centered on our successful Votivo™ biological nematicide, and it allows us to further leverage the biotechnology platform we have acquired through Athenix Corporation," said Sandra Peterson.


"We are proud to become part of Bayer CropScience," AgraQuest CEO Marcus Meadow-Smith commented. "AgraQuest is ideally positioned in the global biological market and by joining forces with Bayer CropScience we will be able to develop revolutionary, tailor-made biological solutions. Every AgraQuest employee is passionate about developing innovative solutions for better food and a better world, and being part of a strong global company such as Bayer CropScience will allow the products developed through their hard work to reach farmers in every corner of the world." AgraQuest has its own sales force in the NAFTA crop protection market, and sells its green products through a network of distributors and partners in other global regions.


The company's current product portfolio includes well-established product brands such as Serenade®, Rhapsody®, Sonata® and Ballad® fungicides and Requiem® insecticides, which provide effective disease and pest control and will complement Bayer CropScience´s product offering. Bayer CropScience will also leverage AgraQuest's technology platform and its promising pipeline of new biological control agents. Several new pipeline products, which include acaracides, fungicides and nematicides, amongst others, are under development, and have undergone successful early field evaluations. Through the acquisition Bayer CropScience will integrate AgraQuest's state-of-the-art biopesticides production facility in Tlaxcala, Mexico, as well as the company's R&D site in Davis. AgraQuest employs a total staff of approximately 250 full-time employees.


AgraQuest products are available today in more than 30 countries including Canada, USA, Mexico, Brazil and European countries including the United Kingdom, Germany, France and Italy. They are used in diverse market segments such as fruits and vegetables, broad-acre crops, post-harvest protection, turf, home and garden and animal health.


About Bayer CropScience

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience, a subgroup of Bayer AG with annual sales of EUR 7.255 billion (2011), is one of the world's leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 21,000 and is represented in more than 120 countries. This and further news is available at:


About AgraQuest

AgraQuest, Inc. is a global biotechnology company that focuses on discovering, manufacturing and marketing highly effective biopesticide products to increase agricultural production.  As a leader in green agriculture and the emerging low chem sector, AgraQuest is at the forefront of changes in food production by providing growers with solutions that offer best-in-class control while reducing the chemical load on the environment and creating sustainable agriculture opportunities. Through its Agriculture and BioInnovations divisions, AgraQuest focuses on natural products designed for pest control and yield improvements for global agriculture, the garden and in food safety markets. AgraQuest's major shareholders include Otter Capital, TPG Biotechnology Partners, Loudwater Investment Partners, Generation Investment Management, Halcyon Capital, SwissRe and several Swiss sustainable investment funds.  For more information, visit"



For further information

Loudwater Investment Partners Limited

Edward Forwood                                                +44 (0)20 3372 6400


Panmure Gordon (UK) Limited

Andrew Potts                                                     +44 (0)20 7459 3600

This information is provided by RNS
The company news service from the London Stock Exchange